Celerion, a global leader in early clinical research services, offers the unique combination of medical expertise, clinical operations experience and scientific excellence giving you the confidence to make fast, accurate decisions about your development path. We provide clinical development services from Phase 1-2b, including patient dose response studies, cardiovascular safety and product labeling studies. We offer data management, site monitoring, biostatistics, and bioanalytical services.